CLINICAL_TRIALS
trial_result
· 2016-01-18
Clinical Trial Update: A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease [Phase 3]
Summary
Multicenter extension study of taliglucerase alfa in pediatric Gaucher disease patients completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-18